Literature DB >> 22039167

Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data.

Bruno Fautrel1, B Combe, N Rincheval, M Dougados.   

Abstract

BACKGROUND: In 2010, new classification criteria for rheumatoid arthritis (RA) were developed.
OBJECTIVE: To assess agreement between 1987 American College of Rheumatology (ACR) and 2010 ACR/European League Against Rheumatism (EULAR) criteria and the potential source of discordance, based on ESPOIR cohort data.
METHODS: 813 early arthritis patients were included in ESPOIR between 2002 and 2005. Between-criteria agreement was based on the κ coefficient. Discordance was explored by logistic regression.
RESULTS: Data for 811 patients were available, with their main characteristics as follows: women 77%, swollen joint count 7.2, tender joint count 8.4, disease activity score in 28 joints 5.2, rheumatoid factor 46%, anticitrullinated protein antibody (ACPA) 39%, structural damage 22%. At baseline, 579 (71.4%) patients met the 1987 ACR criteria and 641 (79.0%) the 2010 criteria. Agreement at baseline was discordant for 168 patients: 115 satisfied the 2010 criteria and 53 the 1987 criteria. Concordance between the two sets was fair, with a κ coefficient of 0.45 and 0.42 at baseline and year 2, respectively. The main sources of discordance were the number and symmetry of joint involvement, as well as ACPA status.
CONCLUSION: 2010 ACR/EULAR criteria identified more patients with RA than did 1987 criteria. The 2010 criteria failed to identify RA patients with symmetrical seronegative arthritis and limited joint involvement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039167     DOI: 10.1136/annrheumdis-2011-200259

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

Review 1.  Rheumatoid arthritis--early diagnosis and disease management.

Authors:  Matthias Schneider; Klaus Krüger
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

2.  Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against Rheumatism criteria for classification of rheumatoid arthritis in the Nurses' Health Study cohorts.

Authors:  Shanthini Kasturi; Barbara L Goldstein; Susan Malspeis; Elizabeth W Karlson; Karen H Costenbader
Journal:  Rheumatol Int       Date:  2013-09-24       Impact factor: 2.631

3.  Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.

Authors:  Liubing Li; Chuiwen Deng; Si Chen; Shulan Zhang; Ziyan Wu; Chaojun Hu; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

4.  SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population.

Authors:  Guodong Xia; Yetian Li; Wei Pan; Chengmei Qian; Lin Ma; Jingli Zhou; Henggui Xu; Chen Cheng
Journal:  J Orthop Surg Res       Date:  2022-01-11       Impact factor: 2.359

5.  The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register.

Authors:  Jennifer H Humphreys; Suzanne M M Verstappen; Kimme L Hyrich; Jacqueline R Chipping; Tarnya Marshall; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2012-09-03       Impact factor: 19.103

6.  Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort.

Authors:  Iuliia Biliavska; Tanja A Stamm; Jose Martinez-Avila; Thomas W J Huizinga; Robert B M Landewé; Günter Steiner; Daniel Aletaha; Josef S Smolen; Klaus P Machold
Journal:  Ann Rheum Dis       Date:  2012-09-15       Impact factor: 19.103

7.  Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort.

Authors:  Karine Chevreul; Georges Haour; Sandy Lucier; Stephanie Harvard; Marie-Laure Laroche; Xavier Mariette; Alain Saraux; Isabelle Durand-Zaleski; Francis Guillemin; Bruno Fautrel
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

8.  Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.

Authors:  Hanna W van Steenbergen; Jessica A B van Nies; Tom W J Huizinga; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2014-04-10       Impact factor: 5.156

9.  Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.

Authors:  Benjamin Granger; Bernard Combe; Xavier Le Loet; Alain Saraux; Francis Guillemin; Bruno Fautrel
Journal:  RMD Open       Date:  2016-05-20

10.  Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.

Authors:  Serena Bugatti; Laura Bogliolo; Barbara Vitolo; Antonio Manzo; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.